MedTrace Logo

MR Elastography in Intracranial Lesions: Feasibility & Accuracy

NCT06916715 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 626

Last updated 2026-04-30

No results posted yet for this study

Summary

Brain tumors, despite their relatively low incidence among cancers, are associated with high morbidity and mortality due to the brain's complexity. Biopsy, the gold standard for tumor grading, is limited by invasiveness, costs, and sampling issues. Conventional MR imaging lacks sensitivity to differentiating tumor grades, while magnetic resonance elastography (MRE) offers non-invasive assessment potential. This retrospective study reviewed MRE data from 626 brain tumor patients (May 2017-September 2025) to evaluate MRE's diagnostic performance, success rate in tumor grading, and clinical reliability, aiming to advance its role in non-invasive brain tumor assessment.

Conditions

  • Brain Neoplasms

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • Yu Shi, MD · Shengjing Hospital

  • Anhua Wu, MD · Shengjing Hospital

  • Wen Cheng, MD · Shengjing Hospital

Eligibility

Min Age
7 Years
Max Age
83 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-09
Primary Completion
2026-09-25
Completion
2026-12-09

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06916715 on ClinicalTrials.gov